Chromocell Therapeutics Corp Contracts & Agreements
78 Contracts & Agreements
- Business Finance (61 contracts)
- Business Operations (1)
- Human Resources (7)
- Intellectual Property (1)
- Mergers & Acquisitions (3)
- Uncategorized (5)
- Form of Indemnification Agreement (Filed With SEC on November 18, 2024)
- Articles of Merger, filed with the Secretary of State of the State of Nevada on November 18, 2024 (Filed With SEC on November 18, 2024)
- Certificate of Ownership and Merger, filed with the Secretary of State of the State of Delaware on November 18, 2024 (Filed With SEC on November 18, 2024)
- Agreement and Plan of Merger, dated as of November 18, 2024 (Filed With SEC on November 18, 2024)
- Second Amendment to the Chromocell Therapeutics Corporation 2023 Equity Incentive Plan (Filed With SEC on November 13, 2024)
- Convertible Note, dated July 24, 2024 (Filed With SEC on July 29, 2024)
- Securities Purchase Agreement by and between the Company and the Holder, dated July 24, 2024 (Filed With SEC on July 29, 2024)
- Common Stock Purchase Agreement by and the Company and Tikkun, dated July 26, 2024 (Filed With SEC on July 29, 2024)
- Registration Rights Agreement by and between the Company and Tikkun, dated July 26, 2024 (Filed With SEC on July 29, 2024)
- Employment Agreement (Francis Knuettel II) (Filed With SEC on May 15, 2024)
- Promissory Note Issued by the Company (Camden Capital) (Filed With SEC on May 15, 2024)
- Side Letter to Amended and Restated Consultant Agreement (Camden Capital) (Filed With SEC on May 15, 2024)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on April 16, 2024)
- Representatives Warrant (Filed With SEC on February 22, 2024)
- Letter Agreement to Underwriting Agreement, dated as of February 16, 2024, between the Company and A.G.P./Alliance Global Partners, as Representative of the Underwriters (Filed With SEC on February 22, 2024)
- Underwriting Agreement, dated February 15, 2024, between the Company and A.G.P./Alliance Global Partners, as Representative of the Underwriters (Filed With SEC on February 22, 2024)
- Fourth Amendment to Senior Secured Convertible Note (April Bridge Financing) (Filed With SEC on February 12, 2024)
- First Amendment to Senior Secured Convertible Note (September Bridge Financing) (Filed With SEC on February 12, 2024)
- Stock Rescission Agreement (Filed With SEC on February 12, 2024)
- Sixth Amended and Restated Investor Promissory Note Issued by the Company (Filed With SEC on January 30, 2024)
- Side Letter to Fifth Amended and Restated Investor Promissory Note Issued by the Company (Filed With SEC on January 30, 2024)
- Form of Representatives Warrant (Filed With SEC on January 30, 2024)
- Form of Underwriting Agreement (Filed With SEC on January 30, 2024)
- Stock Issuance Agreement (Benuvia License Agreement) (Filed With SEC on January 16, 2024)
- Third Amendment to Senior Secured Convertible Note (April Bridge Financing) (Filed With SEC on January 16, 2024)
- Side Letter to Fourth Amended and Restated Investor Promissory Note Issued by the Company (Filed With SEC on January 16, 2024)
- Fifth Amended and Restated Investor Promissory Note Issued by the Company (Filed With SEC on January 16, 2024)
- Second Amended and Restated October Promissory Note Issued by the Company (AME Equities LLC) (Filed With SEC on January 16, 2024)
- Second Amended and Restated October Promissory Note Issued by the Company (Balmoral Financial Group LLC) (Filed With SEC on January 16, 2024)
- Second Amended and Restated October Promissory Note Issued by the Company (Camden Capital LLC) (Filed With SEC on January 16, 2024)
- Second Amended and Restated October Promissory Note Issued by the Company (MDB Merchants Park LLC) (Filed With SEC on January 16, 2024)
- Amendment No. 1 to Director Promissory Note Issued by the Company (Filed With SEC on January 16, 2024)
- Side Letter re Securities Purchase Agreement (Standby Shares) (Filed With SEC on January 16, 2024)
- Benuvia License Agreement (Filed With SEC on January 16, 2024)
- Amended and Restated October Promissory Note Issued by the Company (AME Equities LLC) (Filed With SEC on November 8, 2023)
- Amended and Restated October Promissory Note Issued by the Company (Balmoral Financial Group LLC) (Filed With SEC on November 8, 2023)
- Amended and Restated October Promissory Note Issued by the Company (Camden Capital LLC) (Filed With SEC on November 8, 2023)
- Amended and Restated October Promissory Note Issued by the Company (MDB Merchants Park LLC) (Filed With SEC on November 8, 2023)
- Second Amendment to Senior Secured Convertible Note (April Bridge Financing) (Filed With SEC on October 25, 2023)
- First Amendment to Senior Secured Convertible Note (April Bridge Financing) (Filed With SEC on October 25, 2023)
- First Amendment to Senior Secured Convertible Note (April Bridge Financing) (Filed With SEC on October 16, 2023)
- Form of Underwriting Agreement (Filed With SEC on October 16, 2023)
- Amendment No. 1 to Third Amended and Restated Investor Promissory Note issued by the Company (Filed With SEC on October 16, 2023)
- Side Letter to Third Amended and Restated Investor Promissory Note issued by the Company (Filed With SEC on October 16, 2023)
- Fourth Amended and Restated Investor Promissory Note issued by the Company (Filed With SEC on October 16, 2023)
- October Promissory Note Issued by the Company (AME Equities LLC) (Filed With SEC on October 16, 2023)
- October Promissory Note Issued by the Company (Balmoral Financial Group LLC) (Filed With SEC on October 16, 2023)
- October Promissory Note Issued by the Company (Camden Capital LLC) (Filed With SEC on October 16, 2023)
- October Promissory Note Issued by the Company (MDB Merchants Park LLC) (Filed With SEC on October 16, 2023)
- Form of Senior Secured Convertible Promissory Note (September Bridge Financing; included in Exhibit 10.6) (Filed With SEC on October 16, 2023)
- Securities Purchase Agreement (Series B Preferred Stock) (Filed With SEC on October 16, 2023)
- Registration Rights Agreement (Series B Preferred Stock) (Filed With SEC on October 16, 2023)
- Form of Senior Secured Convertible Promissory Note (September Bridge Financing; included in Exhibit 10.6) (Filed With SEC on September 1, 2023)
- Form of Underwriting Agreement (Filed With SEC on September 1, 2023)
- Side Letter to Contribution Agreement (Filed With SEC on September 1, 2023)
- Third Amended and Restated Investor Promissory Note Issued by the Company (Filed With SEC on September 1, 2023)
- Side Letter to Second Amended and Restated Investor Promissory Note issued by the Company (Filed With SEC on September 1, 2023)
- Amended and Restated Employment Agreement (Christian Kopfli) (Filed With SEC on September 1, 2023)
- Security Agreement (September Bridge Financing) (Filed With SEC on September 1, 2023)
- Subordination and Intercreditor Agreement (September Bridge Financing) (Filed With SEC on September 1, 2023)
- Form of Securities Purchase Agreement (Series B Preferred Stock) (Filed With SEC on September 1, 2023)
- Form of Registration Rights Agreement (Series B Preferred Stock) (Filed With SEC on September 1, 2023)
- Form of Amendment to Chromocell Therapeutics Corporation 2023 Equity Incentive Plan (Filed With SEC on September 1, 2023)
- Form of Representatives Warrant (Filed With SEC on July 20, 2023)
- Form of Advisor Warrant (Filed With SEC on July 20, 2023)
- Form of Senior Secured Convertible Promissory Note (Bridge Financing; included in Exhibit 10.4) (Filed With SEC on July 20, 2023)
- Security Agreement (Bridge Financing) (Filed With SEC on July 20, 2023)
- Form of Securities Purchase Agreement (Series B Preferred Stock) (Filed With SEC on July 20, 2023)
- Employment Agreement (Eric Lang) (Filed With SEC on June 30, 2023)
- Amended and Restated Consultant Agreement (Camden Capital LLC) (Filed With SEC on June 30, 2023)
- Side Letter to Amended and Restated Investor Promissory Note issued by the Company (Filed With SEC on June 30, 2023)
- Second Amended and Restated Investor Promissory Note Issued by the Company (Filed With SEC on June 30, 2023)
- Contribution Agreement (Filed With SEC on January 20, 2023)
- Consulting Agreement (Francis Knuettel II) (Filed With SEC on January 20, 2023)
- Employment Agreement (Christian Kopfli) (Filed With SEC on January 20, 2023)
- Chromocell Therapeutics Corporation 2023 Equity Incentive Plan (Filed With SEC on January 20, 2023)
- Director Promissory Note Issued by the Company (Filed With SEC on January 20, 2023)
- Investor Promissory Note Issued by the Company (Filed With SEC on January 20, 2023)
